WAVE Clinical Platform vs Viz SDH

Viz SDH (Tool B) demonstrates strong usability through its mobile application for real-time alerts and image previews, seamlessly integrating into existing radiology and clinical workflows. Its reported 90% click-through rate on clinical alerts indicates high user engagement and effective workflow integration. While WAVE Clinical Platform (Tool A) also integrates with EMRs and mobile devices for real-time data display, Viz.ai provides more concrete evidence of user adoption and streamlined processes.

WAVE Clinical Platform (Tool A) offers broad clinical value as the first FDA-cleared AI patient surveillance system, providing early warning of general patient deterioration up to six hours in advance. A key study at UPMC showed zero unexpected deaths in the trial cohort compared to six in the control group, highlighting its significant impact on preventing adverse events across a wide patient population. While Viz SDH (Tool B) provides critical, time-sensitive detection for subdural hemorrhage, Tool A's broader preventative scope and compelling outcome data give it an edge in overall clinical value.

Viz SDH (Tool B) offers greater transparency with a clear subscription-based pricing model tied to the number of algorithms and population served, and explicitly states HIPAA compliance and BAA availability. Its widespread adoption in nearly 2,000 hospitals and reported profitability in its healthcare business suggest a strong, validated value proposition. In contrast, WAVE Clinical Platform (Tool A) requires direct contact for pricing, BAA, and HIPAA compliance details, indicating less transparency.

Viz SDH (Tool B) exhibits superior enterprise readiness with its cloud-based deployment, adoption in nearly 2,000 hospitals including most of the largest health systems, and comprehensive security and privacy program with certifications like SOC 2 Type II, HIPAA, and ISO standards. This robust infrastructure and transparent compliance posture facilitate easier integration and scalability for large healthcare organizations. While WAVE Clinical Platform (Tool A) integrates with EMRs and is used in top academic centers, its client-server architecture and 'contact vendor' approach for critical compliance details suggest a potentially more complex enterprise deployment and less transparent security profile.

While WAVE Clinical Platform (Tool A) was a pioneering 'first FDA-cleared AI patient surveillance system,' Viz SDH (Tool B) demonstrates broader and more recognized innovation. Viz.ai has received numerous prestigious awards, including multiple Edison Awards and a Prix Galien USA Award, and was recognized as one of Fast Company's Most Innovative Companies. Furthermore, Viz.ai was the first company to receive CMS reimbursement for AI, showcasing its leadership in advancing healthcare AI and expanding its platform across various disease states.

Viz SDH (Tool B) provides clear and comprehensive support, including 24/7 urgent phone support with a 15-minute response time, in-app support, and a dedicated customer success team with clinical and workflow specialists. They also offer a 'Trust Center' for access to security and compliance documentation. WAVE Clinical Platform (Tool A) lacks specific public information regarding its support structure, response times, or dedicated customer success resources, making Viz.ai's offerings more transparent and robust.